Local research. Human connections. WCR Miami Lakes (786) 483-7856
Back to study searchNCT06108336
RecruitingNCT06108336ClinicalTrials.gov record

Cerebellar Involvement in Cognitive Sequencing

Effects of Cerebellar Stimulation on Brain Activation

THE QUICK READ

What this study involves

The registry says this study is recruiting. Individual locations may have different availability.

Study type
Interventional
Phase
Not applicable
Age range
18 years - 50 years
Sex eligible
All sexes
Healthy volunteers
Accepted
Participants
50 Estimated

These are starting points, not an eligibility decision. The research team must review the full requirements.

About the research

Although there is increasing recognition that the cerebellum is involved in cognition as well as motor function, the manner in which the cerebellum contributes to cognition is uncertain. One theory that might account for both motor and cognitive contributions of the cerebellum is that the cerebellum is involved in sequencing of relevant events or stimuli. Previous experiments have suggested that disruption of the cerebellum impairs the prediction of the next event in a sequence. The present experiment will examine the impact of cerebellar stimulation on brain activation during the performance of both sequence-demanding and non-sequence-demanding tasks.

Read the full description

Although there is increasing recognition that the cerebellum, which contains half of the brain's neurons, is involved in cognition as well as motor function, the manner in which the cerebellum contributes to cognition is uncertain. The uniform circuitry of the cerebellum and the extensive connectivity of the cerebellum with numerous neocortical regions has suggested to some researchers that there is a common computation that the cerebellum performs for both motor and cognitive functions. The cerebellar sequencing hypothesis posits that the cerebellum acquires sequence information, makes sequence predictions, and detects sequence violations. These functions, executed via a forward model, could underlie cerebellar involvement in both motor and cognitive behavior. In motor control, such predictions can be used to guide limb trajectory without reliance on movement-generated sensory feedback. In cognition, sequencing requirements are prominent in both verbal working memory (VWM) and language acquisition; eg, in VWM, keeping a phone number in mind requires encoding and rehearsing a sequence of digits. In language, words consist of sequences of syllables, and the learning of syllable transition probabilities is an important component of recognizing legal words in a language. Importantly, prominent cerebellar activation has been observed in many functional MRI (fMRI) VWM and language studies. However, the brainstem/cerebellar neural correlates of sequencing in cognition, and the influence of cerebellar sequence predictions on neocortical targets, are poorly understood. In this experiment, studying healthy individuals the investigators will Investigate the cerebellum as a source of sequence prediction and its influence on forebrain areas. The cerebellum is hypothesized to provide its forward model sequence prediction to forebrain targets, but to date no study has attempted to visualize with concurrent TMS/fMRI the consequences of disrupting this cerebellar input on forebrain activation. In the investigators previous work, the investigators show that transcranial magnetic stimulation (TMS) during the rehearsal of a sequence of letters results in errors in determining if a probe letter matches the next letter in the sequence, suggesting that TMS disrupted this predictive input. In accordance with this finding, the investigators hypothesize that, using concurrent TMS/fMRI, TMS disruption during a sequencing task will produce greater changes in neocortical activation relative to an analogous control task that does not have the predictive component brought out by sequencing demands. The investigators further hypothesize that different patterns of neocortical activations in response to cerebellar TMS will be observed depending on whether a probe letter matches the expected next letter in a sequence.

Who may be able to participate?

The list below is the sponsor’s full registry wording. It can include conditions, prior treatment, test results and other requirements. A match in search does not mean you qualify.

Inclusion Criteria:

  • 1\) Age 18-50;
  • 2\) educational attainment of at least 8 years;
  • 3\) capable of giving informed consent;
  • 4\) fluent speaker of English by self-report;
  • 5\) right handed.

Exclusion Criteria:

  • 1\) illicit drug use within 30 days of MRI scanning;
  • 2\) neurological or systemic disorder which can cause dementia or cognitive dysfunction;
  • 3\) history of an Axis I psychiatric disorder including substance use disorder;
  • 4\) history of definite stroke;
  • 5\) focal lesion on MRI exam;
  • 6\) uncorrected visual deficits by self-report
  • 7\) contraindications for MRI scanning
  • 8\) use of anxiolytic, antidepressant, neuroleptic, or sedative medication
  • 9\) Additional exclusion criteria recommended by Wassermann for TMS neuromodulation, including: History of seizure or a family history of epilepsy, heart disease, intracardiac lines, increased intracranial pressure, history of head trauma, and history of respiratory disease
Understand screening

Treatment, groups and participation

The registry may describe treatments and study duration without a complete visit calendar. Ask the study team for the exact schedule, procedures, risks, costs and alternatives. Keep your usual care plan unless your treating clinician tells you otherwise.

Assignment
Not randomized
Masking
No masking
Cerebellar Stimulation

TMS will be administered to the cerebellum on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task. Task order will be counterbalanced.

Procedure: TMS during sequence-demanding task · Procedure: No TMS during sequence-demanding task · Procedure: TMS during non-sequence-demanding task · Procedure: No TMS during non-sequence-demanding task

Occipital Stimulation

TMS will be administered to an occipital control region on half the trials of a sequence-demanding task, and on half the trials of a non-sequence-demanding task. Task order will be counterbalanced.

Procedure: TMS during sequence-demanding task · Procedure: No TMS during sequence-demanding task · Procedure: TMS during non-sequence-demanding task · Procedure: No TMS during non-sequence-demanding task

TMS during sequence-demanding task PROCEDURE

TMS is administered during the execution of sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity

No TMS during sequence-demanding task PROCEDURE

TMS is not administered during the execution of sequence-demanding task.

TMS during non-sequence-demanding task PROCEDURE

TMS is administered during the execution of non-sequence-demanding task. Transcranial magnetic stimulation (TMS) is a safe and non-invasive technique for transiently modulating brain activity

No TMS during non-sequence-demanding task PROCEDURE

TMS is not administered during the execution of non-sequence-demanding task

Prepare your questions

What researchers are measuring

Outcome measures describe what is being studied. They are not proof that a treatment works.

Primary measures

functional magnetic resonance imaging brain activation

Time frame: during scan up to 1 hour

functional magnetic resonance imaging brain activation. For the sequential task, a sequence of letters is presented and the subject is presented with number signs, one at a time, to guide rehearsal of the sequence. At some point a probe letter is presented and the subject indicates by button press if the probe is the next letter in the sequence. For the non-sequential task, subjects do not have a guided rehearsal, and the response to the probe indicates if the probe was one of the letters originally presented. Brain activation in response to the probe will be measured with brain stimulation vs no brain stimulation for each task

Secondary measures

percent correct of behavioral responses

Time frame: during scan up to 1 hour

percent correct of behavioral responses. For the sequential task, a sequence of letters is presented and the subject is presented with # signs, one at a time, to guide rehearsal of the sequence. At some point a probe letter is presented and the subject indicates by button press if the probe is the next letter in the sequence. For the non-sequential task, subjects do not have a guided rehearsal, and the response to the probe indicates if the probe was one of the letters originally presented. Behavioral accuracy consists of the percent of correct responses to the probe, with higher numbers indicating better performance

behavioral reaction time (milliseconds)

Time frame: during scan up to 1 hour

behavioral reaction time to respond to the probe. Increases in reaction time indicate greater difficulty for the subject to respond

No results are flagged as posted.

Review the complete result tables and limitations in the official record.

Open official results ↗

Research locations (1)

The overall study status and a local site’s status can differ. Confirm that location’s availability before traveling.

1 locations

Johns Hopkins University School of MedicineBaltimore, Maryland, United StatesRecruiting
John E. Desmond, Ph.D.CONTACT
View location on map ↗

Study team and timeline

Lead sponsor
Johns Hopkins University
Study start
Mar 1, 2024 Actual
Primary completion
Dec 30, 2026 Estimated
Study completion
Jul 31, 2027 Estimated
First posted
Oct 31, 2023 Actual
Last updated
Nov 10, 2026 Actual

Official study contacts

John E Desmond, Ph.D.CONTACTjdesmon2@jhmi.edu410-502-3583
JoAnna Mathena, MSCONTACTlabnim@jh.edu443-571-0947
Official study title

Investigation of Cerebellar Involvement in Cognitive Sequencing

A HUMAN NEXT STEP

Ask Wellness Clinical Research

Your message goes to WCR, including when this study is run by another organization. WCR may offer general guidance but may not operate this trial, have access to its team or be able to enroll you.

Please do not include medical records, diagnoses, medications, insurance numbers or other sensitive details. This form is for general questions, not urgent care.

Sending a question does not enroll you in a trial.

Source: ClinicalTrials.gov API v2. Information is submitted by sponsors and investigators. NLM does not approve the safety or science of all listed studies. Registry disclaimer.

Retrieved: Nov 11, 2026 · Last registry update: Nov 10, 2026